Premium
Non‐alcoholic fatty liver disease to metabolic dysfunction‐associated fatty liver disease : Conceptual changes for clinicians, researchers and patients
Author(s) -
Lin Shuang Zhe,
Chen Yuan Wen,
Fan Jian Gao
Publication year - 2020
Publication title -
journal of digestive diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.684
H-Index - 51
eISSN - 1751-2980
pISSN - 1751-2972
DOI - 10.1111/1751-2980.12944
Subject(s) - fatty liver , disease , medicine , etiology , chronic liver disease , steatohepatitis , alcoholic liver disease , liver disease , intensive care medicine , gastroenterology , cirrhosis
Non‐alcoholic fatty liver disease (NAFLD) is now the most common etiology of chronic liver disease threatening global public health. However, the name “NAFLD” is no longer appropriate with the change of time. Recently, a new term, “metabolic dysfunction‐associated fatty liver disease” has been proposed by an international panel of experts, which implies profound conceptual changes in terms of its metabolism‐related etiology and disease heterogeneity. In this article we discuss the specific conceptual changes that clinicians, researchers and patients must absorb.